SBFMW (Sunshine Biopharma) Other Net Income (Loss) : $-0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sunshine Biopharma Other Net Income (Loss)?

Sunshine Biopharma's Other Net Income (Loss) for the three months ended in Jun. 2024 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00 Mil.

Sunshine Biopharma's quarterly Other Net Income (Loss) declined from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($-0.00 Mil) but then increased from Mar. 2024 ($-0.00 Mil) to Jun. 2024 ($0.00 Mil).

Sunshine Biopharma Other Net Income (Loss) Historical Data

The historical data trend for Sunshine Biopharma's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunshine Biopharma Other Net Income (Loss) Chart

Sunshine Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

-0.58

Sunshine Biopharma Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Sunshine Biopharma Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Sunshine Biopharma Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Sunshine Biopharma's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunshine Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunshine Biopharma Inc (NAS:SBFMW) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

SBFM:USA

Address

6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, QC, CAN, H9R 0A5

Website

https://www.sunshinebiopharma.com

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).